Why is Windlas Biotech falling/rising?

As of 24-Jul, Windlas Biotech Ltd is experiencing a price increase, currently at Rs 979.00, reflecting a rise of Rs 51.6 or 5.56%. The stock has shown strong performance today, outperforming its sector by 5.21% and achieving a consecutive gain over the last two days with a total return of 6.8%. It reached an intraday high of Rs 1023.2, indicating positive momentum. Over the past week, the stock has gained 4.32%, and over the last month, it has increased by 10.66%. Despite a year-to-date decline of 5.27%, the stock has generated a significant return of 36.70% over the past year, outperforming the BSE500 index consistently for the last three years. However, it is trading at a premium compared to its peers, and while it has a low debt-to-equity ratio and a fair valuation, its operating profit growth has been modest.
Broader market context shows that Windlas Biotech's recent performance contrasts with the Sensex, which has seen a slight decline of 0.09% over the past week. The stock's liquidity remains adequate, although there has been a notable decrease in investor participation, with delivery volume falling by 23.61% against the five-day average. This decline in participation could indicate some caution among investors despite the stock's recent gains. Overall, while Windlas Biotech has demonstrated strong short-term performance and consistent returns, concerns about long-term growth and flat results in recent financial periods may temper investor enthusiasm.